PMVP PMV Pharmaceuticals Inc.
FDA Catalyst Company
14.13
+1.49 (+12%)
Previous Close
12.65
Open
13.12
52 Week Low
11.44
52 Week High
37.3199
Market Cap
$644,189,550
Shares
45,574,075
Float
36,584,540
Enterprise Value
$310,594,641
Volume
464,492
Av. Daily Volume
917,100
Live cash est
$88,666,444,222
Cash Burn
N/A
No. Mths Cash
12
Insiders %
0.2
Total debt to equity
4.35
Earnings Date
01/01/2001
EPS EST.
1.82
EPS PRIOR.
1.82
EPS
1.82
Rev guidance
$10,459,000,000
Biotech Analyst Ratings
Analyst | Action | Rating Now | PT Prior | PT Now | Last Updated |
---|---|---|---|---|---|
Oppenheimer | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 03/02/2022 |
Goldman Sachs | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 09/22/2021 |
Oppenheimer | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 08/19/2021 |
Guggenheim | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 08/02/2021 |
HC Wainwright & Co. | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 07/29/2021 |